CD22 Recombinant Rabbit mAb (SDT-R113)

產(chǎn)品型號(hào)：S0B2137

更新時(shí)間：2025-06-30

廠商性質(zhì)：生產(chǎn)廠家

訪問量：29

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

大鼠免疫球蛋白的結(jié)構(gòu)與功能研究

IHC腫瘤標(biāo)志物 | 常見前列腺癌診斷

IHC腫瘤標(biāo)志物 | 常見肺癌診斷

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風(fēng)險(xiǎn)中的診斷潛力

產(chǎn)品介紹

CD22 and CD19 represent two specialized costimulatory or coreceptor cell surface molecules [PMID: 9476671, PMID: 9175829, PMID: 15364057, PMID: 9203413, PMID: 9047233] that also function as “response regulators" to modulate the intensity, quality, and duration of homeostatic and BCR‐induced signals [PMID: 9695183, PMID: 9695185]. Response regulators carry out broader functions than costimulatory molecules because they establish intrinsic signaling thresholds that provide a context for other transmembrane and cytoplasmic signals. CD22 is also a lectin‐like member of the Ig superfamily expressed exclusively by all mature B‐lineage cells, which binds ligands in vivo to regulate BCR and CD19 signal transduction, and provide essential survival signals.

上一個(gè)：S0B2138S-RMab? CK5/6 Recombinant Rabbit mAb (SDT-P004)